trending Market Intelligence /marketintelligence/en/news-insights/trending/HfzW7do-bIYIS3vXUR7P9w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Sweden's Elekta gains US FDA approval for diffusion-weighted images

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


Sweden's Elekta gains US FDA approval for diffusion-weighted images

Elekta AB (publ) said the U.S. Food and Drug Administration approved the use of Elekta Unity in diffusion-weighted imaging.

The FDA clearance allows diffusion-weighted images derived using Elekta Unity to be interpreted by trained physicians.

Diffusion-weighted imaging is a technique that uses the motion of water molecules to create contrast in magnetic resonance images.

The Stockholm-based company's Elekta Unity technology allows doctors to better target cancers and allows for personalized radiation therapy regimens.